WallStSmart
OCGN

Ocugen Inc

NASDAQ: OCGN · HEALTHCARE · BIOTECHNOLOGY

$1.48
+5.38% today

Updated 2026-06-04

Market cap
$419.77M
P/E ratio
P/S ratio
94.01x
EPS (TTM)
$-0.24
Dividend yield
52W range
$1 – $3
Volume
6.9M

Ocugen Inc (OCGN) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20122013201420152016201720182019202020212022202320242025
Operating cash flow$-12.23M$-15.28M$-18.41M$-30.03M$-25.74M$-23.02M$-15.78M$-16.89M$-14.71M$-47.94M$-60.08M$-62.05M$-42.14M$-56.96M
Capital expenditures$79000.00$604000.00$3.32M$1.95M$320000.00$276000.00$2.01M$29446.00$306825.00$939000.00$4.46M$10.48M$3.38M$185000.00
Depreciation
Stock-based comp$14000.00$158000.00$547000.00$1.23M$1.55M$1.57M$1.63M$884089.00$660000.00$6.96M$10.54M$9.22M$7.43M$7.71M
Free cash flow$-12.31M$-15.89M$-21.73M$-31.98M$-26.06M$-23.30M$-17.79M$-16.92M$-15.02M$-48.88M$-64.54M$-72.53M$-45.53M$-57.15M
Investing cash flow
Financing cash flow
Dividends paid$6.80M
Share repurchases
Debt repayment
Net change in cash$-27.61M$993000.00$-24.83M$5.82M$16.60M$70.92M

Frequently asked questions

What is Ocugen Inc's revenue?

Ocugen Inc's trailing twelve-month revenue is $4.46M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is OCGN?

In its most recent fiscal year, OCGN ran a gross margin of 45.86%, an operating margin of -1,425.70%, and a net margin of -1,537.41%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does OCGN generate?

OCGN produced $-57.15M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.